These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23513049)

  • 1. Left ventricular dysfunction with pulmonary hypertension: Part 1: epidemiology, pathophysiology, and definitions.
    Georgiopoulou VV; Kalogeropoulos AP; Borlaug BA; Gheorghiade M; Butler J
    Circ Heart Fail; 2013 Mar; 6(2):344-54. PubMed ID: 23513049
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary hypertension due to left heart disease.
    Berthelot E; Bailly MT; Hatimi SE; Robard I; Rezgui H; Bouchachi A; Montani D; Sitbon O; Chemla D; Assayag P
    Arch Cardiovasc Dis; 2017; 110(6-7):420-431. PubMed ID: 28411107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension and right ventricular dysfunction in left heart disease (group 2 pulmonary hypertension).
    Wilson SR; Ghio S; Scelsi L; Horn EM
    Prog Cardiovasc Dis; 2012; 55(2):104-18. PubMed ID: 23009907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension and right ventricular function in advanced heart failure.
    Kalogeropoulos AP; Vega JD; Smith AL; Georgiopoulou VV
    Congest Heart Fail; 2011; 17(4):189-98. PubMed ID: 21790969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Hypertension secondary to Left Heart Disease.
    Kabbach G; Mukherjee D
    Curr Vasc Pharmacol; 2018; 16(6):555-560. PubMed ID: 28901848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary artery diastolic pressure gradient as an indicator of severity of illness in patients with pulmonary hypertension related to left-sided heart disease.
    Howard C; Rangajhavala K; Safdar Z
    Ther Adv Respir Dis; 2015 Apr; 9(2):35-41. PubMed ID: 25721948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of β-Blockers in Pulmonary Hypertension.
    Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.
    Soma J
    Blood Press; 2011 Jun; 20(3):129-33. PubMed ID: 21142436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hypertension in end-stage renal disease: three case reports].
    Pabst S; Hammerstingl C; Hundt F; Gerhardt T; Nickenig G; Woitas R; Skowasch D
    Dtsch Med Wochenschr; 2011 May; 136(18):944-7. PubMed ID: 21526458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging.
    Olivotto I; Cecchi F; Poggesi C; Yacoub MH
    Circ Heart Fail; 2012 Jul; 5(4):535-46. PubMed ID: 22811549
    [No Abstract]   [Full Text] [Related]  

  • 12. A diagnostic algorithm for pulmonary hypertension due to left heart disease in resource-limited settings: can busy clinicians adopt a simple, practical approach?
    Dzudie A; Kengne AP; Lamont K; Dzekem BS; Aminde LN; Abanda MH; Thienemann F; Sliwa K
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):61-67. PubMed ID: 30534850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastolic heart failure.
    Frigerio M; Aguggini G
    Ital Heart J; 2004 Jun; 5 Suppl 6():48S-54S. PubMed ID: 15185915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.
    van Wolferen SA; Marcus JT; Boonstra A; Marques KM; Bronzwaer JG; Spreeuwenberg MD; Postmus PE; Vonk-Noordegraaf A
    Eur Heart J; 2007 May; 28(10):1250-7. PubMed ID: 17242010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction.
    Haddad F; Vrtovec B; Ashley EA; Deschamps A; Haddad H; Denault AY
    Curr Opin Cardiol; 2011 Mar; 26(2):123-31. PubMed ID: 21297465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary hypertension with left heart disease: a concise review.
    Desai A; Desouza SA
    Vasc Health Risk Manag; 2017; 13():415-420. PubMed ID: 29158679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of pulmonary hypertension on outcomes of patients with low left ventricular ejection fraction: a propensity analysis.
    Yang C; Li D; Mennett R; Hammond J; Zhang G; Chen D; Lundbye J; Gallagher R
    J Heart Valve Dis; 2012 Nov; 21(6):767-73. PubMed ID: 23409360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.
    Samson R; Jaiswal A; Ennezat PV; Cassidy M; Le Jemtel TH
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26811159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.